Target intelligence / Profile preview

Microvascular circulation

Molecular classification
Other (system of small blood vessels, including arterioles, capillaries, venules; composed of cell types such as endothelial cells, pericytes, smooth muscle cells)
01

Overview

Microvascular circulation encompasses the movement of blood within the smallest vessels (arterioles, capillaries, venules) of an organ’s microvasculature. This system is essential for delivering oxygen and nutrients, removing metabolic waste, regulating vascular resistance, and maintaining tissue homeostasis. Microcirculatory dysfunction contributes to various clinical syndromes, particularly cardiovascular diseases, via mechanisms such as microvascular spasm, impaired perfusion, increased endothelial permeability, glycocalyx degradation, and inflammatory cell plugging. Therapeutic strategies typically target the underlying pathophysiology at the level of endothelial cells, smooth muscle cells, or mediators regulating vascular tone and immune responses rather than the microvascular circulation itself.

Other names
Microcirculationmicrovasculaturemicrovessels
02

Mechanism of action

Improving microvascular perfusion through vasodilation (e.g., nitric oxide donors) Reducing platelet and leukocyte adhesion (antiplatelet and anticoagulant drugs) Protecting the endothelial barrier/glycocalyx Modulating signaling pathways involved in vascular tone (e.g., inhibition of angiotensin II receptor)

03

Biological functions

Oxygen and nutrient deliveryCarbon dioxide and waste removalRegulation of blood flow and tissue perfusionMaintenance of vascular barrier and permeability (via endothelial glycocalyx)Hemostasis and immune cell trafficking
04

Disease associations

Cardiovascular disease (including coronary microvascular disease, ischemia, myocardial infarction, hypertension)Inflammation and reperfusion injuryEdema and tissue injury
05

Safety considerations

Therapeutic challenges include irreversibility of established microvascular obstructionRisks of bleeding with potent antiplatelet/anticoagulant therapiesEdema due to increased permeability from glycocalyx degradationIndividual variability, especially sex differences (higher risk in women for small vessel disease)
06

Interacting drugs

antiplatelet agents

6 more in the full profile.

07

Biomarkers

Index of microvascular resistance (IMR)Cardiac magnetic resonance imaging (for coronary microvascular obstruction)Functional capillary density (FCD)Endothelial glycocalyx integrity

Beyond the preview

Go deeper on Microvascular circulation.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Microvascular circulation.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call